SCHEMBL7653794

SCHEMBL7653794

CCOC(=O)Nc1ccc2[nH]c3c(c2c1)CC(N(C)C)CC3

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.67
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PABPC1 P11940 1/20 0.44
ATM Q13315 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 3/20 0.42
ALOX15 P16050 2/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HTR1A P08908 3/20 0.41
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666163 0.90 HTR1F (0.71) HTR1FKMT2AMEN1LMNASMN1; SMN2
SCHEMBL7662499 0.89 HTR1F (0.64) HTR1FKMT2AMEN1SMN1; SMN2ATM
SCHEMBL7662072 0.87 HTR1F (0.68) HTR1FKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL11334169 0.85 HTR1F (0.74) HTR1FKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL7655520 0.85 HTR1F (0.68) HTR1FKMT2AMEN1LMNASMN1; SMN2
SCHEMBL7653801 0.84 HTR1A (0.48) HTR1FKMT2AMEN1LMNASMN1; SMN2
SCHEMBL7407071 0.83 HTR1F (0.71) HTR1FKMT2AMEN1LMNASMN1; SMN2
SCHEMBL7663867 0.83 HTR1F (0.71) HTR1FKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL7658586 0.83 HTR1F (0.83) HTR1FKMT2AMEN1LMNASMN1; SMN2
SCHEMBL7659297 0.83 HTR1F (0.76) HTR1FKMT2AMEN1HTR1AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed